Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years | BTVB Bioequivalence of von Willebrand factor-containing concentrates: implications for von Willebrand disease | BTVB Cardiovascular risk in hormone replacement therapy | BTVB Direct oral anticoagulants: does one dose fit all? Why, when and how testing | BTVB Cardiovascular risk profile evolution over 15 years: CV-PREVITAL vs Moli-sani Study | BTVB Launch of National Registry for Congenital Hematological Disorders in Palestine: Haemo-PAL | BTVB

This journal has not published any issues.

Impact Factor 2025

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Anticoagulation in obese patients: challenges and strategies

Alice Lipari, Esmeralda Capristo, Antonietta Ferretti, Erica De Candia

18-09-2025

https://doi.org/10.4081/btvb.2025.174

2017

PDF: 519

HTML: 302

XML: 185
The history of the TIMI, GISSI, and ISIS trials: the development of thrombolytic therapy in acute myocardial infarction

Aldo Pietro Maggioni, Claudio Fresco, Luigi Tavazzi

13-10-2026

https://doi.org/10.4081/btvb.2026.577

12

PDF: 6
The key to fibrinolysis and thrombolysis

Roger Lijnen, Désiré Collen

09-09-2025

https://doi.org/10.4081/btvb.2025.368

1676

PDF: 517

HTML: 260
Executive summary of the SISET position paper on the management of antithrombotic therapy in left ventricular thrombus

Emanuele Valeriani, Arianna Pannunzio, Danilo Menichelli, Domenico Prisco, Walter Ageno, Daniele Pastori, Pasquale Pignatelli

16-12-2025

https://doi.org/10.4081/btvb.2025.401

440

PDF: 130

HTML: 110

1 - 4 of 4 items

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.